Induction of IL-4-Producing CD4+ T Cells by Antigenic Peptides Altered for TCR Binding

Journal of Immunology

Volumn 158, Issue 9, 1997, Pages 4237-4244

  Tao, Xiang ^a   Grant, Catriona ^a   Constant, Stephanie ^a   Bottomly, Kim ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; INTERLEUKIN 4; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CYTOLOGY; DENDRITIC CELL; DOSE RESPONSE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; MOUSE; SPLEEN; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CYTOCHROME C GROUP; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; INTERLEUKIN-4; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 0031137616     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. LeGros, G., S. Z. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of IL4 producing cells in vivo and in vitro: IL2 and IL4 are required for in vitro generation of IL4 producing cells. J. Exp. Med. 172:92.
2. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
3. Mannetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (IL-12) induces T helper type 1-specific immune response and inhibits the development of IL-4-producing cells. J. Exp. Med. 177:119.
4. Heinzel, F. P., D. S. Schoenhaut, R. M. Reko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
5. Sypek, J. P., C. L. Chung, S. E. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. B. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
6. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
7. + T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285.
8. Parish, C. R. 1971. Immune response to chemically modified flagellin. I. Induction of antibody tolerance to flagellin by acetoacetylated derivatives of the protein. J. Exp. Med. 134:1.
9. Hauser, C., C. M. Snapper, J. Ohara, W. E. Paul, and S. I. Katz. 1989. T helper cells grown with hapten-modified cultured Langerhans' cells produce interleukin 4 and stimulate IgE production by B cells. Eur. J. Immunol. 19:245.
10. Pfeiffer, C., J. Murray, J. Madri, and K. Bottomly. 1991. Selective activation of Th1 and Th2 like cells in vivo: response to human collagen IV. Immunol. Rev. 123:65.
11. Bretscher, P. A., G. Wei, J. Menon, and H. J. Bielefeld-Ohmann. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539.
12. Fox, B. S. 1993. Antigen presenting cell-derived co-stimulatory signals can selectively regulate IL-2 and IL-4 production from a Th0 cell hybridoma. Int. Immunol. 5:323.
13. Hosken, N. A., K. Shibuya, A. W. Heath, K. M. Murphy, and A. O'Garra. 1995. The effect of antigen dose on CD4 T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Immunol. 182:1579.
14. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569.
15. + T cells. J. Exp. Med. 182:1591.
16. Sloan-Lancaster, J., and P. M. Allen. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1.
17. Evavold, B. D., and P. M. Allen. 1991. Separation of IL4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308.
18. Evavold, B. D., J. Sloan-Lancaster, and P. M. Allen. 1994. Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand. Proc. Natl. Acad. Sci. USA 91:2300.
19. Nicholson, L. B., J. M. Greer, R. A. Sobel, M. B. Lees, and V. K. Kuchroo. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3:397.
20. Windhagen, A., C. Scholz, P. Hollsberg, H. Fukaura, A. Sette, and D. A. Hafler. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2:373.
21. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 341:746.
22. Jones, B. 1983. Evidence that the Thy-1 molecule is the target for T cell mitogenic antibody against brain-associated antigens. Eur. J. Immunol. 13:678.
23. Landais, D., C. Waltzinger, B. M. Beck, A. Staub, D. J. McKean, C. Benoist, and D. Mathis. 1986. Functional sites on Ia molecules: a molecular dissection of A alpha immunogenicity. Cell 47:173.
24. Murray, J. S., C. Pfeiffer, J. Madri, and K. Bottomly. 1992. MHC control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype. Eur. J. Immunol. 22:559.
25. Swiggard, W., R. M. Nonacs, M. Witmer-Pack, and R. M. Steinman. 1992. Enrichment of dendritic cells by plastic adherence and EA rosetting. In Current Protocols in Immunology, Vol. 1, Suppl. 3. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Green Publishing Associates, and John Wiley and Sons, New York, p. 3.7.1.
26. + T cells to protein antigens in vivo. 1995. J. Immunol. 155:3734.
27. Openshaw, P., E. E. Murphy, N. A. Hosken, V. Maino, K. Davis, K. M. Murphy, and A. O'Garra. 1995. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182:1357.
28. Jorgensen, J. L., P. A. Reay, E. W. Ehrich, and M. Davis. 1992. Molecular components of T-cell recognition. Annu. Rev. Immunol. 10:835.
29. Fox, B. S., C. Chen, E. Fraga, C. A. French, B. Singh, and R. H. Schwartz. 1987. Functionally distinct agretopic and epitopic sites: analysis of the dominant T cell determinant of moth and pigeon cytochrome c with the use of synthetic peptide antigens. J. Immunol. 139:1578.
30. Hansburg, D., T. Fairwell, R. H. Schwartz, and E. Appella. 1983a. The T lymphocyte response to cytochrome c. IV. Distinguishable sites on a peptide antigen which affect antigenic strength and memory. J. Immunol. 131:319.
31. Hansburg, D., E. Heber-Katz, T. Fairwell, and E. Appella. 1983b. Major histocompatibility complex-controlled, antigen-presenting cell-expressed specificity of T cell antigen recognition: identification of a site of interaction and its relationship to Ir genes. J. Exp. Med. 158:25.
32. Reay, P. A., R. M. Kantor, and M. M. Davis. 1994. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152:3946.
33. + thymocytes by T-cell receptor antagonists. Proc. Natl. Acad. Sci. USA 91:4057.
34. Lyons, D. S., S. A. Lieberman, J. Hamp, J. J. Boniface, Y. Chien, L. J. Berg, and M. M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5:53.
35. Pure, E., K. Inaba, and J. Metlay. 1988. Lymphokine production by murine T cells in the mixed leukocyte reaction. J. Exp. Med. 168:795.
36. Metlay, J. P., E. Pure, and R. M. Steinman. 1989. Distinct features of dendritic cells and anti-Ig activated B cells as stimulators of the primary mixed leukocyte reaction. J. Exp. Med. 169:239.
37. + T cells. Annu. Rev. Immunol. 12:635.
38. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
39. + T cells into IL-4-secreting cells. J. Immunol. 152:5180.
40. Sloan-Lancaster, J., A. S. Shaw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell 79:913.
41. Madrenas, J., R. I. Wange, J. L. Wang, N. Isakov, L. E. Samelson, and R. N. Germain. 1995. ζ Phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 276:515.
42. Kuchroo, V. J., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. W. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
43. Lenschow, D. J., C. H. Stephen, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
44. Racioppi, L., F. Ronchese, L. A. Matis, and R. N. Germain. 1993. Peptide-major histocompatibility complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1047.
45. Wauben, M. H., C. S. Boog, R. van der Zee, I. Joosten, A. Schlief, and W. van Eden. 1992. Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone. J. Exp. Med. 176:667.
46. Wraith, D. C. 1995. Induction of antigen-specific unresponsiveness with synthetic peptides: specific immunotherapy for treatment of allergic and autoimmune conditions. Int. Arch. Allergy Immunol 108:355.
47. Karin, N., D. J. Mitchell, S. Brocke, N. Ling, and L. Steinman. 1994. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production. J. Exp. Med. 180:2227.